A bend in the road--implications of ACTG 175 and Delta trials.
Hirsch
M S
MS
Yeni
P
P
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001315:Australia; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005060:Europe; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D016019:Survival Analysis; D014481:United States; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine